CLDX
Price
$36.90
Change
-$1.20 (-3.15%)
Updated
Sep 11 closing price
Capitalization
2.9B
60 days until earnings call
Intraday BUY SELL Signals
DYN
Price
$18.21
Change
-$0.21 (-1.14%)
Updated
Sep 11 closing price
Capitalization
3.4B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLDX vs DYN

CLDX vs DYN Comparison Chart in %
View a ticker or compare two or three
VS
CLDX vs. DYN commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and DYN is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($3.4B) has a higher market cap than CLDX($2.9B). CLDX YTD gains are higher at: 35.862 vs. DYN (-6.902). CLDX has higher annual earnings (EBITDA): -322.43M vs. DYN (-502.36M). DYN has more cash in the bank: 898M vs. CLDX (718M). CLDX has less debt than DYN: CLDX (4.9M) vs DYN (219M). CLDX has higher revenues than DYN: CLDX (158K) vs DYN (0).
CLDXDYNCLDX / DYN
Capitalization2.9B3.4B85%
EBITDA-322.43M-502.36M64%
Gain YTD35.862-6.902-520%
P/E RatioN/AN/A-
Revenue158K0-
Total Cash718M898M80%
Total Debt4.9M219M2%
FUNDAMENTALS RATINGS
CLDX vs DYN: Fundamental Ratings
CLDX
DYN
OUTLOOK RATING
1..100
5851
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4261
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8524

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DYN's Valuation (36) in the Electric Utilities industry is somewhat better than the same rating for CLDX (94) in the Biotechnology industry. This means that DYN’s stock grew somewhat faster than CLDX’s over the last 12 months.

DYN's Profit vs Risk Rating (97) in the Electric Utilities industry is in the same range as CLDX (100) in the Biotechnology industry. This means that DYN’s stock grew similarly to CLDX’s over the last 12 months.

DYN's SMR Rating (98) in the Electric Utilities industry is in the same range as CLDX (98) in the Biotechnology industry. This means that DYN’s stock grew similarly to CLDX’s over the last 12 months.

CLDX's Price Growth Rating (42) in the Biotechnology industry is in the same range as DYN (61) in the Electric Utilities industry. This means that CLDX’s stock grew similarly to DYN’s over the last 12 months.

CLDX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as DYN (100) in the Electric Utilities industry. This means that CLDX’s stock grew similarly to DYN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXDYN
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 19 days ago
78%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
83%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (CLDX: $36.90 vs. DYN: $18.21)
Brand notoriety: CLDX and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 119% vs. DYN: 148%
Market capitalization -- CLDX: $2.9B vs. DYN: $3.4B
CLDX [@Biotechnology] is valued at $2.9B. DYN’s [@Biotechnology] market capitalization is $3.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green while DYN’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 5 TA indicator(s) are bullish while DYN’s TA Score has 4 bullish TA indicator(s).

  • CLDX’s TA Score: 5 bullish, 5 bearish.
  • DYN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than DYN.

Price Growth

CLDX (@Biotechnology) experienced а -7.01% price change this week, while DYN (@Biotechnology) price change was -25.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

CLDX is expected to report earnings on Nov 11, 2026.

DYN is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CLDX
Daily Signal:
Gain/Loss:
DYN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QGRW66.850.56
+0.84%
WisdomTree U.S. Quality Growth ETF
GEME42.060.24
+0.58%
Pacific NoS Global EM Equity Active ETF
RAAA25.060.03
+0.14%
Reckoner Yield Enhanced AAA CLO ETF
PUSH50.180.02
+0.04%
PGIM Ultra Short Municipal Bond ETF
TINT39.67N/A
N/A
ProShares Smart Materials ETF

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with VIR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-3.15%
VIR - CLDX
48%
Loosely correlated
+0.38%
STOK - CLDX
47%
Loosely correlated
-1.06%
KURA - CLDX
46%
Loosely correlated
-1.56%
EDIT - CLDX
45%
Loosely correlated
+1.89%
SANA - CLDX
45%
Loosely correlated
+1.29%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-1.14%
RNA - DYN
64%
Loosely correlated
+0.10%
RCKT - DYN
47%
Loosely correlated
-3.74%
BBIO - DYN
46%
Loosely correlated
-0.08%
IDYA - DYN
45%
Loosely correlated
+0.37%
CLDX - DYN
45%
Loosely correlated
-3.15%
More